Gemtuzumab ozogamicin
Drug timelines are a Plus or Pro feature.
36 regulatory and trial events tracked for Gemtuzumab ozogamicin, covering 2009-12-25 to 2026-04-14. Get the full timeline:
Most recent: Clinical Trial Update: A Phase Ia/Ib Trial of Revumenib Combined With Cytarabine, Daunorubicin, and Gemtuzumab Ozogamicin (GO) in Frontline and Relapsed /Refractory Pediatric Acute Leukemia Patients [Phase 1]